Quantum Cyber N.V. Depreciation Expense
Quantum Cyber N.V. (QUCY) reported Depreciation Expense of $139.27 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2025-09-26
- Quantum Cyber N.V. depreciation expense for the quarter ending 2023-12-31 was $67.51K.
- Quantum Cyber N.V. depreciation expense for the quarter ending 2023-09-30 was $22.54K.
- Quantum Cyber N.V. depreciation expense for the quarter ending 2023-06-30 was $82.29K.
- Quantum Cyber N.V. depreciation expense for the quarter ending 2023-03-31 was $30.64K.
| Period end | Depreciation Expense 3 month | Depreciation Expense 6 month | Depreciation Expense 9 month | Depreciation Expense 12 month | Depreciation Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | $139.27K 6-K · filed 2025-09-26 | ||||
| 2024-12-31 | $319.45K 20-F · filed 2025-03-31 | ||||
| 2024-06-30 | $104.02K 6-K · filed 2025-09-26 | ||||
| 2023-12-31 | $67.51K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $90.05K derived: sum of 2 quarters · filed 2025-03-31 | $172.34K derived: sum of 3 quarters · filed 2025-03-31 | $202.98K 20-F · filed 2025-03-31 | |
| 2023-09-30 | $22.54K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $104.83K derived: sum of 2 quarters · filed 2023-11-16 | $135.47K 6-K · filed 2023-11-16 | ||
| 2023-06-30 | $82.29K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $112.93K 6-K · filed 2023-08-15 | |||
| 2023-03-31 | $30.64K 6-K · filed 2023-05-16 | ||||
| 2022-12-31 | $43.54K 20-F · filed 2025-03-31 | ||||
| 2021-12-31 | $6.57K 20-F · filed 2024-04-09 | $6.37K 20-F · filed 2022-05-03 | |||
| 2020-12-31 | $4.67K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |